Orelabrutinib
目录号: A22225
BTK inhibitor
Orelabrutinib(ICP-022)是一种强效的、口服活性的、不可逆的Bruton's tyrosine kinase (BTK) 抑制剂,具有潜在的抗肿瘤活性。
Discription | Orelabrutinib (ICP-022) is a potent, orally active, and irreversible Bruton's tyrosine kinase (BTK) inhibitor with potential antineoplastic activity. |
---|
目录号 | A22225 |
---|---|
分子式 | C26H25N3O3 |
分子量 | 427.5 |
CAS号 | 1655504-04-3 |
SMILES | O=C(C1=CC=C(C2CCN(C(C=C)=O)CC2)N=C1C3=CC=C(OC4=CC=CC=C4)C=C3)N |
其他名称 | ICP-022 |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2